Latest Dividend Declaration Could Be a Game Changer for Baxter International (BAX)

• Baxter International’s Board of Directors recently declared a quarterly cash dividend of US$0.17 per share, payable on October 1, 2025, to shareholders of record as of August 29, 2025, with an indicated annual dividend rate of US$0.68 per share.
• This dividend declaration highlights the company’s ongoing focus on returning value to shareholders and suggests continued confidence in its financial stability.
• We'll explore how Baxter’s latest dividend announcement underscores management’s confidence amid ongoing business transformation and evolving industry challenges.

Outshine the giants: these 19 early-stage AI stocks could fund your retirement.

Baxter International Investment Narrative Recap

To be a Baxter International shareholder today, you need confidence in the company’s ongoing business transformation and its ability to improve execution despite industry volatility and recent leadership changes. The latest quarterly dividend declaration at US$0.17 per share does not appear material enough to shift attention from the critical short-term catalysts, such as potential product-driven revenue growth, or the largest risk, including uncertainty from global tariffs and CEO transition.

Among recent developments, the appointment of Andrew Hider as CEO, effective September 2025, stands out as highly relevant. Leadership stability is key at a time when Baxter aims to leverage new product launches and operational efficiencies to address margin pressure and evolving market conditions.

However, investors should also consider that, in contrast, new executive leadership may signal increased uncertainty around…

Read the full narrative on Baxter International (it's free!)

Baxter International's outlook anticipates $12.5 billion in revenue and $998.3 million in earnings by 2028. This is based on a projected annual revenue growth rate of 5.2% and a net earnings increase of $1,275.3 million from the current loss of $-277.0 million.

Uncover how Baxter International's forecasts yield a $38.03 fair value, a 38% upside to its current price.

Exploring Other Perspectives

Five independent fair value estimates from the Simply Wall St Community span from US$38.03 to over US$20,500.83. While some see strong growth potential, others remain cautious given ongoing macroeconomic and tariff risks, so it’s worth seeing how these views compare.

Explore 5 other fair value estimates on Baxter International - why the stock might be worth just $38.03!

Build Your Own Baxter International Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Baxter International research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Baxter International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Baxter International's overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com